VerbatimParliament, as it happens

Givinostat

Asked by Freddie van MierloLiberal DemocratDepartment of Health and Social CareTabled Answered 3 February 2025UIN 26988

The question

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of expediting a NICE appraisal for Givinostat.

Answered by Karin Smyth

The National Institute for Health and Care Excellence (NICE) works with companies on timelines for its evaluations of new medicines, and aims, wherever possible, to issue guidance close to the point of licensing to support rapid access for National Health Service patients to clinically and cost-effective medicines. The NICE’s timeline for its evaluation of givinostat was rescheduled at the request of the company, to facilitate a suitably comprehensive and robust submission. The NICE’s Appraisal Committee is due to meet to consider its recommendations on givinostat in May 2025.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim